Abstract
The therapy of pericardial and myopericardial syndromes should be targeted as much as possible to the underlying aetiology. Nevertheless, in clinical practice, many cases remain “idiopathic”, that is without a well-established aetiological diagnosis with a conventional diagnostic approach. Nothing is really “idiopathic”, but in the real world, considering a cost-effective diagnostic approach, as well as the potential risks of additional invasive investigations, it may be rationale and appropriate to provide empiric medical therapies to treat the most probable diagnosis. In developed countries with a low prevalence of tuberculosis, the most common presumed aetiology is viral or immune mediated.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Imazio M, Adler Y. Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis. Heart Fail Rev. 2013;18:355–60.
Imazio M, et al. Medical therapy of pericardial diseases: part II: noninfectious pericarditis, pericardial effusion and constrictive pericarditis. J Cardiovasc Med (Hagerstown). 2010;11:785–94.
Lotrionte M, et al. International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am Heart J. 2010;160:662–70.
Imazio M, Brucato A, Trinchero R, Spodick D, Adler Y. Individualized therapy for pericarditis. Expert Rev Cardiovasc Ther. 2009;7:965–75.
Imazio M, Brucato A, Cumetti D, Brambilla G, Demichelis B, Ferro S, Maestroni S, Cecchi E, Belli R, Palmieri G, Trinchero R. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008;118:667–71.
Ristić AD, et al. Pericardial disease in pregnancy. Herz. 2003;28:209–15.
Imazio M, et al. Management of pericardial diseases during pregnancy. J Cardiovasc Med (Hagerstown). 2010;11:557–62.
Authors/Task Force Members; Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, Brucato A, Gueret P, Klingel K, Lionis C, Maisch B, Mayosi B, Pavie A, Ristić AD, Sabaté Tenas M, Seferovic P, Swedberg K, Tomkowski W. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36:2921–64.
Imazio M. New clinical trials in acute and recurrent pericarditis. Curr Cardiol Rep. 2015;17:23.
Imazio M. Colchicine for pericarditis. Trends Cardiovasc Med. 2015;25:129–36.
Briasoulis A, Afonso L. Prevention of pericarditis with colchicine: an updated meta-analysis. J Cardiovasc Med (Hagerstown). 2015;16:144–7.
Alabed S, Cabello JB, Irving GJ, Qintar M, Burls A. Colchicine for pericarditis. Cochrane Database Syst Rev. 2014;8:CD010652.
Imazio M, Lazaros G, Brucato A, Gaita F. Recurrent pericarditis: new and emerging therapeutic options. Nat Rev Cardiol. 2015. doi:10.1038/nrcardio.2015.115. [Epub ahead of print].
Vianello F, et al. Azathioprine in isolated recurrent pericarditis: a single centre experience. Int J Cardiol. 2011;147:477–8.
Gelfand EW. Intravenous immune globulin in autoimmune and inflammatory diseases. N Engl J Med. 2012;367:2015–25.
del Fresno MR, Peralta JE, Granados MÁ, Enríquez E, Domínguez-Pinilla N, de Inocencio J. Intravenous immunoglobulin therapy for refractory recurrent pericarditis. Pediatrics. 2014;134:e1441–6.
Moretti M, et al. Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. Am J Cardiol. 2013;112:1493–8.
Imazio M, et al. Intravenous human immunoglobulins for refractory recurrent pericarditis. A systematic review of all published cases. J Cardiovasc Med (Hagerstown). 2015. [Epub ahead of print].
Grattagliano I, et al. Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics. Clin Pharmacol Ther. 2014;95:89–97.
Mertens M, Singh JA. Anakinra for rheumatoid arthritis: a systematic review. J Rheumatol. 2009;36:1118–25.
Picco P, et al. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease? Arthritis Rheum. 2009;60:264–8.
Lazaros G, et al. Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases. Ann Rheum Dis. 2014;73:2215–7.
Lazaros G, et al. Anakinra: an emerging option for refractory idiopathic recurrent pericarditis. A systematic review of published evidence. J Cardiovasc Med (Hagerstown). 2015. [Epub ahead of print].
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Imazio, M. (2016). Principles of Medical Therapy of Pericardial Diseases. In: Myopericardial Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-27156-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-27156-9_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-27154-5
Online ISBN: 978-3-319-27156-9
eBook Packages: MedicineMedicine (R0)